KSB advised Dioscorides Global Holdings, LLC
KSB’s advice involved the creation of a mechanism by which DGH will acquire shares in Konomed and the negotiation of additional funding principles, all the while taking into consideration the need for the Investment Agreement, which was governed by the laws of the State of New York, to conform with with Czech corporate law. KSB also helped formulate the fundamental principles of a future acquisition agreement and shareholders’ agreement.
The ICCI (International Cannabis and Cannabinoids Institute) endeavours to explore medical cannabis and its components to treat patients in the future by making „custom-made“ preparations. The Institute will take advantage of the latest knowledge with regard to cannabis and biomedicine within the aim of creating, among other things, a platform for further research, education and sharing information.
Other articles
Helena Navrátilová on Three Decades of the Advent Concerts of Good Will
KŠB partner Helena Navrátilová was recently interviewed on S dobrou vůlí, the podcast of the Committee of Good Will – Olga Havel Foundation. Speaking with editor Veronika Širc, Helena talked about the origins and history of the Advent Concerts of Good Will, which KŠB has been organizing for over thirty years.
KŠB advises LIPOELASTIC founders on the sale of LIPOELASTIC Group
KŠB, in collaboration with investment advisers from the Roklen Group, advised LIPOELASTIC Group founders Alena and Tomáš Hradil on their exit from the group, which they had built up over almost twenty-five years.
Chemistry Brings People Together: KŠB at the 2026 Evening of Czech Chemistry
Czech chemistry and the chemical industry are built on innovation, responsibility and the people who drive the field forward. On Thursday, 22 October 2026, leading figures from the field and industry representatives came together at the Grand Hotel International Prague for the Czech Chemical Industry Association’s annual Evening of Czech Chemistry.
